No single CMS strategy has proven an inarguable success at delivering significant cost savings while optimizing patient outcomes and minimizing clinical risks. Two researchers think they’ve found a way. 

PressGaney market researchers offer three observations on the technology’s potential for optimizing patient satisfaction—and, with it, subsequent ‘PX’ scores.  

Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. New research out of Canada suggests it may make sense in certain scenarios to go straight to the permanent pacemaker. 

Researchers expected these conditions to reduce the benefits of early treatment. However, that was not the case.

What President Trump has in mind is a populace equipped with smartphone apps run by tech companies and confident enough in those apps to willingly upload much if not all of their personal health data. All that and fit kids too. 

Tirzepatide met the primary endpoint of non-inferiority versus dulaglutide, with an 8% lower rate of MACE events included cardiovascular death, heart attack or stroke, while delivering greater reductions in A1C and weight.

Study shows same-day discharge is feasible for carefully selected, uncomplicated ACS patients. 

One imaging policy expert called this stance from ACR and ASRT a “devastating blow” to physician offices and independent diagnostic testing facilities who use virtual supervision for Medicare patients.